SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

A sharp, high-volume rally without a confirmed company announcement is driving discussion, with bulls citing institutional buying and short covering while others speculate about leaked news ahead of an FDA decision on Anktivas bladder-cancer label expansion. The move has renewed debate over Anktivas commercial growth and broader cancer-treatment potential, but the immediate catalyst remains unconfirmed.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

New DefenCath real-world evidence is driving discussion: traders highlight reported reductions in bloodstream infections and hospitalizations in U.S. Renal Care data, while a Fresenius comparison found no significant difference versus ClearGuard. The mixed findings fuel debate over DefenCaths clinical differentiation and adoption, with post-TDAPA reimbursement uncertainty also weighing on sentiment.

Charter Communications, Inc. engages in providing broadband communications services. Its services include Spectrum TV, Spectrum Internet, and Spectrum Voice. It offers business-to-business Internet access, data networking, business telephone, video and music entertainment services, and wireless backhaul. Its advertising sales division, Spectrum Reach, offers local, regional, and national businesses the opportunity to advertise in individual and multiple service areas on cable television networks and advanced advertising platforms. The company was founded in 1993 and is headquartered in Stamford, CT.

Charter Communications Inc. - Ordinary Shares - Class A

Goldmans latest price-target cut and bearish rating are cited as catalysts for CHTRs slide to multi-year lows, alongside concerns about broadband subscriber losses, competition, and its heavy debt burden. Bulls counter that the shares are deeply undervalued given cash flow, mobile growth, and the Cox deal, while bearish traders question whether those strengths can offset the core businesss declines.

Select Sector SPDR Trust (The) - State Street Utilities Select Sector SPDR ETF

Utilities Select Sector SPDR Fund

XLU is drawing attention as traders watch a rebound after a steep utility-sector pullback, with heavy call-option activity fueling hopes that the fund is bottoming. The debate centers on whether the bounce can persist while Treasury yields remain a headwind for rate-sensitive utilities.

Flutter Entertainment Plc engages in the business of online betting and gaming. It operates through the following segments: UK and Ireland, Australia, International, and US. The UK and Ireland segment includes the operations of Sky Betting and Gaming, Paddy Power, Betfair, and tombola. The Australia segment focuses on sports betting services provided to Australian customers online. The International segment relates to poker, casino, rummy, lottery, and sports betting. The US segment includes sports betting, daily fantasy sports, and gaming services. The company was founded in 1988 and is headquartered in New York, NY.

Flutter Entertainment Plc

Flutters shares are under pressure after Brazils executive order halted local online betting, adding to broader concerns about regulation and competition from prediction markets. Traders debate whether Brazils limited contribution to the business justifies the selloff, with some calling the shares undervalued while others see continued downside risk.

Daily surprises, near and far. Your source for travel inspiration and more. Travel moves you!

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Court approval of the settlement cleared a major legal obstacle to Paramounts acquisition of Warner Bros. Discovery, with closing scheduled for October 6. Traders are focused on WBDs narrow gap to the fixed cash buyout value and the remaining per-day fee, though some still note legal challenges and closing uncertainty.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

A weaker-than-expected U.S. jobs report eased rate-hike concerns and Treasury yields, prompting a sharp IWM rebound from its 200-day moving average. Traders welcomed the bounce but questioned its durability, given small caps sensitivity to borrowing costs and their recent underperformance.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. It operates through the Hard Disk Drives (HDD) segment. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Reports that Toshiba plans to expand hard-drive capacity for AI data centers raised concerns about future competition and pressure on WDCs pricing power, weighing on the shares alongside Seagate. Many traders called the selloff an overreaction, citing strong AI-storage demand and the time needed to add capacity, while others warned that added supply could weaken the HDD markets tight conditions.

Harvest Portfolios Group Inc - Harvest Diversified High Income Shares ETF (Class A Units)

Discussion centers on HHIS as a diversified Harvest high-income ETF, with traders sharing product content and focusing on monthly distributions, covered-call income, and Canadian tax efficiency. A reported milestone above $2 billion in assets is also mentioned, while the broader conversation is largely product and portfolio discussion rather than a single market catalyst.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Eras 20-year Vistra power purchase agreement for up to 207 MW at its Texas data-center project is driving attention, with traders viewing it as progress toward attracting a hyperscaler tenant. Optimism about a future lease and possible short covering is tempered by skepticism that a tenant agreement remains unannounced and concerns about potential share dilution and project financing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Analysts Think CorMedix (CRMD) Could Surge 67.73%: Read This Before Placing a Bet

The consensus price target hints at a 67.7% upside potential for CorMedix (CRMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

CorMedix (CRMD) Upgraded to Buy: Here's Why

CorMedix (CRMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Biotech Momentum Meets a Google AI Shockwave: 4 Stocks Traders Are Watching Now

Biotech momentum is carrying forward, as the three biotechs we covered, Picard Medical (NYSEAMERICAN:PMI), NeOnc Technologies (NASDAQ:NTHI), and CorMedix (NASDAQ:CRMD) continue to move, while Rezolve Ai (NASDAQ:RZLV) has introduced a powerful new AI infrastructure catalyst through Google (NASDAQ:GOOG).

CorMedix (CRMD) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Wall Street Analysts Believe CorMedix (CRMD) Could Rally 65.96%: Here's is How to Trade

The consensus price target hints at a 66% upside potential for CorMedix (CRMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

These Stocks are Keeping the Heat Up

The market is once again rewarding companies that can produce a combination of real operating progress, identifiable catalysts and a credible path to growth, including NeOnc (NASDAQ:NTHI), Profusa (NASDAQ:PFSA), CorMedix (NASDAQ:CRMD), IP Strategy (NASDAQ:IPST), Haemonetics (NYSE:HAE), Heartflow (NASDAQ:HTFL), and FreeCast (NASDAQ:CAST).

CRMD Stock Up as Q2 Earnings & Sales Beat on DefenCath, Melinta Gains

CorMedix stock rises 15% after Q2 earnings and revenues beat estimates, driven by solid DefenCath utilization and contributions from the Melinta portfolio.

CorMedix CEO Expects Supplemental Filing For Fungal Disease Treatment By Q3 – CRMD Stock Sees Best Day In Nearly 10 Months After Earnings Beat

Equity

CorMedix expects to submit its supplemental Rezzayo application in Q3, with a potential FDA decision in the first half of 2027.

The Stocks Suddenly Giving Traders Something to Chase

The market is delivering a potent mix of earnings acceleration and fresh corporate catalysts can quickly reshape investor expectations. $CRMD, $XHG, $IVDA, $DFSC, $FGI, $ARX

CorMedix Is Printing Cash: CRMD Drops $101.9M Quarter as DefenCath Takes Off

CorMedix Therapeutics (NASDAQ:CRMD) just delivered another powerful quarter, pairing $101.9 million in Q2 revenue with $58.7 million in adjusted EBITDA while expanding DefenCath’s commercial reach and preparing for a potentially major REZZAYO label expansion.

Extremely Bullish Sentiment

Up more than 5%

Flat to up 5%

Flat to down 5%

Down more than 5%

What&#39;s your expected total return for the S&amp;P 500 ($SPY) in Q4? 

Drop your reasoning in the comments.

Stocktwits

What's your expected total return for the S&P 500 (

) in Q4? 

Drop your reasoning in the comments.

CRMD CorMedix Inc